Test Detail

Golden Retriever muscular dystrophy (GRMD, Duchenne type)

Musculoskeletal · Dog

Golden Retriever muscular dystrophy (GRMD) is an X-linked recessive inherited disease that causes progressive muscle degeneration, homologous to human Duchenne muscular dystrophy. It is characterised by progressive muscle weakness and atrophy with replacement of muscle by fatty and fibrous tissue, affecting skeletal and cardiac musculature.
Inheritance patternX-linked recessive. Hemizygous males are affected; heterozygous females are usually asymptomatic carriers.
Gene / MutationDMD (X chromosome): base change in the 3' consensus splice site of intron 6 that causes skipping of exon 7 and truncation of dystrophin. It is not an exon 69 deletion.
PenetranceHemizygous males and homozygous females develop the disease; heterozygous carriers are usually asymptomatic. Clinical expression varies between individuals.
Sample type0,5 – 1 ML sangre EDTA preferiblemente o 2 Hisopos bucales sin medio de raspado intenso
Codejrtd
Turnaround time7 days
Price52,60 €
BreedsGolden retriever

Incidence

It affects the Golden Retriever and has been documented in several countries. The carrier frequency is not firmly established in the verified sources.

Clinical signs

- Progressive muscle weakness (proximal muscles)
- Difficulty climbing stairs, jumping or walking on uneven ground
- 'Bunny hopping' gait (jumping with both hind legs)
- Muscle atrophy (back, thighs)
- Exercise intolerance
- Dyspnoea due to weakness of intercostal muscles
- Dysphagia in advanced cases
- Cardiac changes (cardiomyopathy) and death from respiratory or cardiac failure

History

GRMD was recognised as the canine homologue of Duchenne muscular dystrophy and is the most widely used spontaneous animal model of this disease. Sharp and colleagues (1992) demonstrated that the cause is an error in dystrophin mRNA processing: a base change in the 3' consensus splice site of intron 6 causes skipping of exon 7 and disruption of the reading frame. The DMD gene encodes dystrophin, a structural protein critical for the integrity of the muscle fibre membrane.

Breeder management

- Test the breeding line (DMD genotyping) before the first mating
- Affected males must not be bred
- Carrier females should only be mated to non-carrier males
- Keep a genetic record in the pedigree
- Monitor cardiac and respiratory function in affected animals

Specialist notes

The differential diagnosis includes mitochondrial myopathies, myasthenia gravis, polymyositis and other muscular dystrophies; the genetic test is definitive. There is no curative treatment: management is supportive (physiotherapy, nutritional support, cardiac and respiratory care). The prognosis is guarded, with survival usually of a few years in severe forms.

References

1. Sharp NJ, Kornegay JN, Van Camp SD, et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics. 1992;13(1):115-121. PMID: 1577476
2. Kornegay JN. The golden retriever model of Duchenne muscular dystrophy. Skelet Muscle. 2017;7(1):9. PMID: 28526070

Add to cart

Price: 52,60 € · Turnaround time: 7 days

Add to cart

← Back to the search